Address
20 On Hatch
Galway, 2
United States of America (the)
Phone
353 1 438 1700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
95000
First IPO Date
March 06, 2017
| Name | Title | Pay | Year Born |
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer | 3.81M | 1970 |
| Thierry Pieton | Executive Vice President & Chief Financial Officer | 421,766 | 1970 |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary | 985,574 | 1969 |
| Brett A. Wall | Executive Officer | 1.86M | 1966 |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing | 0 | 1979 |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer | 0 | N/A |
| Mark Ploof | Senior Vice President of Global Operations and Business Services | 0 | N/A |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer | 0 | N/A |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer | 0 | 1970 |
| Alex Gu | Senior VP & President of Greater China Region | 0 | N/A |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business | 0 | N/A |
| Ingrid Goldberg | Vice President & Head of Investor Relations | 0 | N/A |
Medtronic plc operates on a global scale, designing, producing, and distributing sophisticated device-based medical treatments. These solutions cater to a broad spectrum of users, including healthcare systems, medical practitioners, clinicians, and patients worldwide. Within its Cardiovascular division, Medtronic supplies a comprehensive array of products aimed at heart health. This includes implantable devices such as pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. The segment also covers cardiac ablation solutions, compact insertable cardiac monitors, TYRX products, and sophisticated remote monitoring and patient-focused software. Furthermore, it delivers various valve technologies, including aortic valves, items for surgical valve replacement and repair, and transcatheter pulmonary valves. The portfolio extends to advanced endovascular stent grafts and their associated accessories, alongside percutaneous coronary intervention (PCI) tools and angioplasty balloons. The Medical Surgical division provides a wide spectrum of offerings for operating rooms and beyond. These encompass surgical instruments like stapling devices, vessel sealing tools, wound closure solutions, and electrosurgery products. It also embraces cutting-edge technologies such as surgical artificial intelligence and robotic-assisted surgery platforms. Specialized products address hernia repair (mechanical devices and mesh implants), gynecology, and lung conditions. Additionally, this segment extends into minimally invasive diagnostics and treatments for gastrointestinal and hepatological conditions, patient monitoring systems, therapies for airway management and ventilation, and solutions for renal disease. Medtronic's Neuroscience division caters to a diverse group of medical professionals, including spinal and neurosurgeons, neurologists, pain management experts, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, interventional radiologists, and ENT specialists. Its product range features advanced energy surgical instruments, sophisticated image-guided and intra-operative imaging systems, and robotic guidance platforms specifically for robot-assisted spinal operations. Moreover, the segment delivers critical therapies for the cerebral and surrounding vasculature. Finally, the Diabetes Operating Unit focuses on solutions for diabetes management, supplying insulin pumps with associated consumables, continuous glucose monitoring (CGM) systems, and intelligent insulin pen systems, along with their necessary supplies. Established in 1949, Medtronic maintains its corporate headquarters in Dublin, Ireland.